6-Methoxy-1,2,3,4-Tetrahydroisoquinoline, 95.0%, 1g

Fmoc-(R)-3-Amino-4-(4-Trifluoromethyl-phenyl)-butyric acid, 97%, 1g

6-(4-bromophenyl)pyridazin-3-ol, 95.0%, 1g

N-methyl-N-(phenylsulfonyl)glycine, 99.0%, 500mg

Icosanoic acid, 95.0%, 1g

Trimethyl((tetrahydro-2H-pyran-4-yl)ethynyl)silane, 98%, 250mg

2-Iodo-6-methylpyridin-3-amine, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-isopropylphenyl)propanoic acid, 98%, 1g

Tributylamine, min.99%, pour la synthèse, 2,5 L, emballage en verre

4-Bromoisophthalic Acid>97.0%(GC)(T)10g

5-(1-adamantyl)-2,4-dihydroxybenzoic acid, 1g

1-Eicosene, 97.0%, 1g

Sofosbuvir impurity L, 1mg